Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Alzheimer's Disease: Mechanisms, Upstream Drivers and Neuroprotection

A neurodegeneration brief on amyloid plaques and tau tangles, the microbial, metabolic and inflammatory drivers behind them, and the nutrients claimed to protect neurons.

Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026

Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.

What we found that needs correcting

  • 'Type 3 diabetes' is presented as settled. It is a nickname used by some researchers, not an official diagnosis, and trials of insulin and diabetes drugs in Alzheimer's have so far been disappointing.
  • The antimicrobial shield theory is presented as established. Beta-amyloid does behave like a germ-trapping protein in laboratory work, and the shingles vaccine study in Wales strengthened the infection angle, but contrary evidence exists and the theory is not settled.
  • The anti-amyloid antibody entry leaves out the main risk. Lecanemab and donanemab cause brain swelling or small bleeds (ARIA) in a substantial minority, require regular MRI monitoring, carry higher risk in APOE4 carriers, and are only for people in the early stage who meet strict criteria.
  • The nutrient table is stronger than the evidence. The B vitamin entry is the closest to real: the VITACOG trial in 271 people with mild cognitive impairment slowed brain shrinkage, most clearly in those with high homocysteine. But a pooled analysis of 11 trials in about 22,000 people found no effect on memory and thinking, so B vitamins are not established as preventing Alzheimer's. Omega-3, vitamin D, magnesium L-threonate, CoQ10 and curcumin have not been shown to prevent or treat it.
  • What is missing is the prevention evidence with the biggest numbers behind it: the 2024 Lancet Commission found that around 45% of dementia worldwide is linked to 14 risk factors that can be changed, including hearing loss, blood pressure, cholesterol, smoking and inactivity.
  • The core biology, including plaques and tangles, the 15 to 20 year head start, microglial activation, APOE4 risk of roughly 3-fold for one copy and 8 to 12-fold for two, and the glymphatic clearance of waste during deep sleep, matches what we found in the research.

Download the PDF

All source documents